Ozempic and Liver Disease? Here’s What You Need to Know

We’ve covered the rising popularity of semaglutide—better known by its brand names like Ozempic, Wegovy, and Rybelsus—and we’ve discussed its potential benefits and very real risks.

Now, researchers are exploring whether this GLP-1 drug might help treat a serious liver condition known as MASH (metabolic dysfunction-associated steatohepatitis), a dangerous form of fatty liver disease.

The findings? Promising—but as always, we urge caution.

We’re not here to sell drugs or push Big Pharma’s latest breakthrough. Our goal is simple: to keep you informed—so you can make the best decision for your health.

MASH, formerly grouped under “nonalcoholic fatty liver disease,” is more than just fat buildup in the liver. It also involves inflammation, liver cell damage, and scarring (fibrosis)—which, if left untreated, can lead to cirrhosis or liver failure.

In a 72-week Phase 3 clinical trial spanning 37 countries, researchers tested semaglutide in 800 people with biopsy-confirmed MASH and liver fibrosis. Over half of them also had type 2 diabetes, and nearly three-quarters were obese.

Participants were randomly assigned to receive either weekly 2.4mg semaglutide injections or a placebo, alongside standard care.

Here’s what they found:

• 63% of those taking semaglutide saw their liver inflammation resolve without fibrosis getting worse.
• 36.8% showed improvement in fibrosis without worsening inflammation.
• And 33% achieved both outcomes—double the success rate of the placebo group.

On top of that, participants on semaglutide lost an average of 10.5% of their body weight, while those in the placebo group lost only 2%.

So… is semaglutide the solution?

Not so fast.

This drug, while effective in some areas, also came with drawbacks. A staggering 86% of semaglutide users reported side effects—mostly gastrointestinal, including nausea, vomiting, and constipation. And as we’ve seen before, not everyone tolerates these symptoms well.

Plus, let’s not ignore this critical point: Many of the benefits may be due to weight loss, not the drug itself.

“Because the greatest contributor to MASH is obesity, I believe this is more a function of weight loss than a direct effect of the medication,” said bariatric surgeon Dr. Mir Ali.

In other words: It’s not the semaglutide that’s healing the liver. It’s the metabolic improvements that come from shedding the weight.

That’s good news. Because there are plenty of ways to support healthy weight loss and liver function—without relying on a weekly injection.

Whether or not semaglutide becomes a go-to liver treatment down the road, the take-home message is clear: MASH is driven by metabolic dysfunction. Fix that, and your liver has a fighting chance.

Here are a few proven, natural ways to support liver and metabolic health:

• Adopt a Mediterranean-style diet: Rich in olive oil, leafy greens, fatty fish, and nuts—this eating pattern reduces inflammation and supports weight loss without calorie counting.
• Ditch sugar and refined carbs: These spike insulin, feed liver fat, and are major contributors to MASH. Prioritize whole foods over processed snacks and drinks.
• Exercise regularly: Even moderate walking or resistance training can improve insulin sensitivity and help reduce liver fat.

Try liver-supportive supplements:

• Milk thistle (silymarin) has antioxidant and liver-regenerating properties.
• Berberine supports blood sugar balance and may mimic some GLP-1 effects naturally.
• N-acetylcysteine (NAC) and alpha-lipoic acid help reduce oxidative stress and support detox pathways.
• Support gut health: Your gut microbiome influences liver inflammation. Probiotic foods and prebiotic fiber can reduce liver fat and inflammation over time.

Semaglutide shows potential. But let’s not mistake it for a magic fix. For some people, particularly those with advanced disease or multiple comorbidities, the benefits may outweigh the risks.

But for most, natural solutions remain the safer, smarter first step.

As always, we’ll continue to bring you the latest findings—so you can make informed, empowered choices based on what works best for you.

To staying informed,

Rachel Mace
Managing Editorial Director, e-Alert
with contributions from the research team

Sources:

Freeborn, J. (2025, May 13). Diabetes and weight loss drug semaglutide may also treat liver disease. Medicalnewstoday.com; Medical News Today. https://www.medicalnewstoday.com/articles/diabetes-weight-loss-drug-semaglutide-ozempic-may-also-treat-liver-disease#Can-semaglutide-be-used-to-treat-liver-conditions